Medindia
Medindia LOGIN REGISTER
Advertisement

Ortho Biotech, L.P. and Centocor, Inc. Alert Authorized Distributors and Prescribing Physicians About Stolen Product

Friday, May 16, 2008 General News
Advertisement
HORSHAM, Pa., May 15 JOM Pharmaceutical Services, Inc.(JOM), a service coordinator that provides delivery services and customersupport to Centocor, Inc. and Ortho Biotech, L.P., was notified May 6, 2008,that a transport trailer carrying DOXIL(R) (doxorubicin HCl liposomeinjection), PROCRIT(R) (epoetin alfa) and REMICADE(R) (infliximab) was stolenwhile the driver was traveling from a distribution center in Kentucky to aspecialty distributor. This incident has been reported to local and federallaw enforcement offices, as well as the U.S. Food and Drug Administration;however, the transport trailer and product have not yet been recovered.
Advertisement

To ensure patient safety, Centocor and Ortho Biotech are voluntarilywithdrawing products with lot numbers matching those of the stolen productfrom the market and communicating this action to all authorized distributorsand all prescribing physicians, healthcare providers, and patients.
Advertisement

If the stolen product were to be reintroduced into distribution channels,the companies cannot guarantee that products were stored at appropriatetemperatures, nor can the companies guarantee the products were not damaged.A voluntary withdrawal of products with lot numbers corresponding to that ofthe stolen product minimizes the possibility of inadvertent use of stolenproduct by physicians and, therefore, the overall risk to patients.

On May 7, 2008, JOM discontinued shipment of products with lot numbersmatching those of the stolen product. Healthcare providers and patients thatdid receive product shipped from an authorized distributor on or before thisdate should consider the product safe for use. Healthcare providers andpatients that are concerned about products shipped after this date with thefollowing NDC and lot numbers can return the product by contacting thecompanies at (888) 626-5660:

No other lot numbers of product are impacted by this incident. All threeof these products have tamper-evident features that can be used toauthenticate the package. Healthcare professionals and patients who haveconcerns about any product they possess may contact the number below forassistance with the identification of these features.

The amount of stolen and withdrawn product represents a very smallproportion of the total product within the distribution channel; therefore thecompanies do not anticipate a disruption in product availability for patients.

JOM, Centocor, and Ortho Biotech will continue to work closely withhealthcare providers and authorized distribution partners to identify andisolate product with lot numbers corresponding to those of the stolen product,and ask that anyone report any questionable activities to the appropriateauthorities. Healthcare professionals, distributors or patients are asked todirect questions related to this voluntary withdrawal to the companies bycalling (888) 626-5660.

Please see Important Safety Information for REMICADE(R) (infliximab),PROCRIT(R) (epoetin alfa), and DOXIL(R) (doxorubicin HCl liposome injection)at their respective websites.

About JOM Pharmaceutical Services, Inc.

JOM Pharmaceutical Services, Inc. is a service provider that is dedicatedto providing safe and on-time delivery of pharmaceutical products for OrthoBiotech, L.P., Centocor, Inc., and other U.S. pharmaceutical companies.

About Ortho Biotech, L.P.

Ortho Biotech Products, L.P. is a leading biopharmaceutical companydevoted to helping improve the lives of patients with cancer and with anemiadue to multiple causes, including chronic kidney disease. Since it wasfounded in 1990, Ortho Biotech and its worldwide affiliates have earned aglobal reputation for researching, manufacturing and marketing innovativeproducts that enhance patients' health. Located in Bridgewater, N.J., OrthoBiotech is an established market leader in Epoetin alfa therapy for anemiamanagement.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close